Awarefy Inc. (Headquarters: Shinjuku-ku, Tokyo; CEO: Shinichiro Ogawa, hereinafter "Awarefy") and the "Mental Health Research Institute" (Director: Hikari Takashina, hereinafter "Kokoro Soken"), operated by Awarefy, have released the analysis results of the "Cognitive Behavioral Therapy Awareness Survey (May 2026)" conducted on approximately 950 individuals residing in Japan. This survey was conducted to understand the current state of awareness, access, and system recognition of Cognitive Behavioral Therapy (CBT) as of the end of May 2026, ahead of the medical fee revision (hereinafter referred to as "this revision") concerning CBT and psychological support premiums, which will be implemented in June 2026. Survey Results Summary Over 70% experienced mental distress in the past year, but less than 20% utilized specialized institutions. CBT is the least "well-known" among mental healthcare methods. Compared to mindfulness, approximately 50% are "not well-informed" about CBT (around 30% for mindfulness/meditation), indicating a significant difference in awareness. CBT's intention to "receive treatment" does not easily translate into actual use. While 14.5% have thought about wanting to receive it, only 3.5% have actually done so. As a background, 9.2% stated "wanted to receive it but couldn't," suggesting that a considerable number of people are unable to access treatment despite their intention. The barriers to accessing CBT identified in this survey are: 1st place "Don't know where to receive it," 2nd place "Expensive/financially difficult," and 3rd place "Uncertain about effectiveness/suitability." Over 90% responded they were "unaware" of this revision. On the other hand, upon learning about the revision, over 60% showed increased interest in receiving CBT. Background and Purpose of This Survey Cognitive Behavioral Therapy (CBT) (*1) is a psychotherapy that addresses patterns of "thinking" and "behavior" that affect mood and actions, and has demonstrated therapeut